To validate this observation, we performed cellular fractionation and showed that ADAM9 proteins were indeed detected in the nuclear fraction of ESCC cells, using two different antibodies against the N-terminal and C-terminal domains of ADAM9, the signals of which were markedly suppressed in ADAM9 knockdown cells (Figure S4A). The gene discussed is ADAM9; the disease is esophageal squamous cell carcinoma.